Calendar Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Real-time Estimate Cboe BZX 11:01:31 2024-04-16 am EDT 5-day change 1st Jan Change
35.42 USD +0.80% Intraday chart for Collegium Pharmaceutical, Inc. -9.05% +14.62%

Chart calendar Collegium Pharmaceutical, Inc.

a7a285f925.yc-3Dgc6IsC_FwylrBYors81D_ac8ePWl7ffegFnsm0.i4z4USppZoftb3TLnENl5IcDXbjtnKyf_v-9HVgk4z6HmdxjKg9A9u1uRQ~e9462d64181fc846912c71509deb16e4

Upcoming events on Collegium Pharmaceutical, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-05-16 08:30 am Annual General Meeting
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)

Past events on Collegium Pharmaceutical, Inc.

2024-04-10 03:45 pm Needham Healthcare Conference - Fireside Chat
2024-02-22 04:30 pm Q4 2023 Earnings Call
2024-02-22 04:09 pm Q4 2023 Earnings Release
2023-11-28 04:00 pm Piper Sandler Healthcare Conference - Fireside Chat
2023-11-14 04:30 am Jefferies London Healthcare Conference - Fireside Chat
2023-11-07 04:30 pm Q3 2023 Earnings Call
2023-11-07 04:01 pm Q3 2023 Earnings Release
2023-09-06 06:30 pm PAINWeek Conference - Association Between Per Capita Prescribing
2023-09-06 06:30 pm PAINWeek Conference - Misuse and Abuse Trends Across COVID-19
2023-09-06 06:30 pm PAINWeek Conference - Use of Causal Framework
2023-09-06 06:30 pm PAINWeek Conference - Real-world Impact of Abuse-Deterrent
2023-09-06 06:30 pm PAINWeek Conference - Severity of Medical Outcomes of Exposures
2023-09-06 06:30 pm PAINWeek Conference - Misuse/Abuse of XTAMPZA
2023-09-06 06:30 pm PAINWeek Conference - Prescription Opioid Misuse/Abuse
2023-09-06 06:30 pm PAINWeek Conference - Safety and Tolerability of Buprenorphine
2023-09-06 06:30 pm PAINWeek Conference - Treatment Characteristics of Chronic Low Back Pain
2023-09-06 06:30 pm PAINWeek Conference - Healthcare Cost and Resource
2023-08-03 04:30 pm Q2 2023 Earnings Call
2023-08-03 04:01 pm Q2 2023 Earnings Release
2023-06-08 12:30 pm Jefferies Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
297
296
0.3%
310
311
-0.33%
277
331
-16.36%
464
460
0.96%
567
565
0.38%

584

EBITDA
Million USD
Released
Forecast
Spread
7,53
4,78
57.64%
140
150
-6.85%
118
165
-28.16%
266
256
3.87%
367
366
0.34%

386

EBIT
Million USD
Released
Forecast
Spread
-23,7
-22,3
-6.56%
56,2
58,0
-3.01%
17,6
70,5
-74.98%
33,3
42,2
-21.08%
167
153
8.91%

215

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-22,7
-22,7
0.08%
27,6
32,9
-16.23%
-3,37
48,3
-106.99%
-28,8
-17,9
-61.49%
75,7
61,4
23.27%

167

Net income
Million USD
Released
Forecast
Spread
-22,7
-23,2
2.09%
26,8
30,1
-11.05%
71,5
109
-34.3%
-25,0
-15,3
-63.32%
48,2
43,2
11.6%

116

EPS
USD
Released
Forecast
Spread
-0,68
-0,71
4.67%
0,76
0,90
-15.93%
1,86
2,89
-35.58%
-0,74
-0,64
-15.18%
1,29
1,10
17.27%

2,95

Announcement Date27/02/2025/02/2124/02/2223/02/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
27,4
81,5
-66.44%
83,8
78,7
6.46%
124
121
1.92%
127
124
2.13%
130
125
3.52%
145
138
4.65%
136
138
-2.07%
137
140
-2.03%
150
148
1.49%

148


142


144


150


152

EBITDA
Million USD
Released
Forecast
Spread
-4,48
41,9
-110.68%
43,5
41,0
6.18%
71,2
64,9
9.61%
74,9
68,6
9.1%
76,4
69,1
10.59%
87,6
88,9
-1.49%
85,8
88,5
-3.02%
89,4
86,7
3.08%
104
99,6
4.62%

94,9


92,8


95,6


103


97,4

EBIT
Million USD
Released
Forecast
Spread
-34,1
18,7
-282.61%
-10,0
11,2
-189.59%
11,1
19,0
-41.55%
20,5
21,4
-4.38%
11,8
20,6
-43.06%
24,6
34,9
-29.48%
35,6
30,6
16.49%
45,0
41,1
9.41%
61,7
48,0
28.43%

54,4


49,8


52,2


58,4


53,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-38,9
12,8
-404.13%
-15,8
0,37
-4389.39%
-6,65
2,40
-377.19%
1,43
0,89
60.54%
-7,79
3,21
-342.84%
-17,6
18,2
-196.52%
17,8
12,2
46.21%
28,8
23,5
22.34%
46,7
32,4
44.1%

40,8


37,4


41,0


48,3


42,5

Net income
Million USD
Released
Forecast
Spread
-25,0
12,3
-303.16%
-13,1
0,24
-5568.2%
-5,19
1,98
-362.44%
0,46
1,27
-64.14%
-7,20
2,49
-388.73%
-17,4
9,59
-281.68%
13,0
11,4
14.15%
20,6
20,6
-0.06%
31,9
23,3
36.86%

25,7


24,7


29,3


36,6


31,4

EPS
USD
Released
Forecast
Spread
-0,73
0,35
-310.07%
-0,39
0,18
-313.7%
-0,15
0,06
-350%
0,01
-0,14
107.41%
-0,22
-0,15
-51.72%
-0,51
0,31
-262.42%
0,34
0,29
18.26%
0,61
0,52
18.06%
0,82
0,60
36.67%

0,65


0,63


0,75


0,94


0,82

Announcement Date24/02/2210/05/2204/08/2203/11/2223/02/2304/05/2303/08/2307/11/2322/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. COLL Stock
  4. Calendar Collegium Pharmaceutical, Inc.